Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Parkinson's Disease

Free Subscription 27.06.2022 1 BMC Neurol 2 Exp Neurol 1 Int J Neurosci 2 J Neural Transm (Vienna) 1 J Neurol Neurosurg Psychiatry 7 Mov Disord 3 Neurobiol Dis 1 Neurochem Res 1 Neurol Clin Pract 1 Neurol Genet 1 Neurology 1 Neuropsychology 4 Neurosci Lett 1 Neuroscience 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. REN K, Chen Z, Ling Y, Zhao J, et al
   Recognition of freezing of gait in Parkinson's disease based on combined wearable sensors.
   BMC Neurol. 2022;22:229.
   PubMed         Abstract available
   
   

   
   Exp Neurol

2. DARCY N, Lofredi R, Al-Fatly B, Neumann WJ, et al
   Spectral and spatial distribution of subthalamic beta peak activity in Parkinson's disease patients.
   Exp Neurol. 2022 Jun 19:114150. doi: 10.1016/j.expneurol.2022.114150.
   PubMed         Abstract available
   
   
3. HUSSEIN A, Tielemans A, Baxter MG, Benson DL, et al
   Cognitive deficits and altered cholinergic innervation in young adult male mice carrying a Parkinson's disease Lrrk2(G2019S) knockin mutation.
   Exp Neurol. 2022 Jun 19:114145. doi: 10.1016/j.expneurol.2022.114145.
   PubMed         Abstract available
   
   

   
   Int J Neurosci

4. OSTREA MC, Rosales RL, Joya-Tanglao M
   Efficacy and safety of apomorphine pump infusion in Filipino patients insufficiently controlled on oral anti-Parkinson medications: an open-label, pilot study.
   Int J Neurosci. 2022 Jun 20:1-10. doi: 10.1080/00207454.2022.2090352.
   PubMed         Abstract available
   
   

   
   J Neural Transm (Vienna)

5. JELLINGER KA
   Morphological basis of Parkinson disease-associated cognitive impairment: an update.
   J Neural Transm (Vienna). 2022 Jun 20. pii: 10.1007/s00702-022-02522.
   PubMed         Abstract available
   
   
6. ERRO R, Sorrentino C, Russo M, Barone P, et al
   Essential tremor plus rest tremor: current concepts and controversies.
   J Neural Transm (Vienna). 2022;129:835-846.
   PubMed         Abstract available
   
   

   
   J Neurol Neurosurg Psychiatry

7. LAWTON M, Tan MM, Ben-Shlomo Y, Baig F, et al
   Genetics of validated Parkinson's disease subtypes in the Oxford Discovery and Tracking Parkinson's cohorts.
   J Neurol Neurosurg Psychiatry. 2022 Jun 22. pii: jnnp-2021-327376.
   PubMed         Abstract available
   
   

   
   Mov Disord

8. WANG P, Pan J, Luo Q, Chen J, et al
   A 10-Year Community-Based Study of Leucine-Rich Repeat Kinase 2 G2385R Carriers' Conversion to Parkinson's Disease.
   Mov Disord. 2022 Jun 22. doi: 10.1002/mds.29127.
   PubMed         Abstract available
   
   
9. STRAKA I, Svantnerova J, Minar M, Stankova S, et al
   Neurodevelopmental Gene-Related Dystonia-Parkinsonism with Onset in Adults: A Case with NAA15 Variant.
   Mov Disord. 2022 Jun 22. doi: 10.1002/mds.29125.
   PubMed        
   
   
10. XIE A, Ensink E, Li P, Gordevicius J, et al
    Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms.
    Mov Disord. 2022 Jun 20. doi: 10.1002/mds.29128.
    PubMed         Abstract available
    
    
11. LUO S, Goetz CG, Choi D, Aggarwal S, et al
    Resolving Missing Data from the Movement Disorder Society Unified Parkinson's Disease Rating Scale: Implications for Telemedicine.
    Mov Disord. 2022 Jun 18. doi: 10.1002/mds.29129.
    PubMed         Abstract available
    
    
12. COKU I, Mutez E, Eddarkaoui S, Carrier S, et al
    Functional Analyses of Two Novel LRRK2 Pathogenic Variants in Familial Parkinson's Disease.
    Mov Disord. 2022 Jun 16. doi: 10.1002/mds.29124.
    PubMed         Abstract available
    
    
13. SCHAEFFER E, Toedt I, Kohler S, Rogge A, et al
    Reply to: "Risk Disclosure in Prodromal Parkinson's Disease".
    Mov Disord. 2022;37:1327.
    PubMed        
    
    
14. MORRIS LA, O'Callaghan C, Le Heron C
    Disordered Decision Making: A Cognitive Framework for Apathy and Impulsivity in Huntington's Disease.
    Mov Disord. 2022;37:1149-1163.
    PubMed         Abstract available
    
    

    
    Neurobiol Dis

15. WILLIAMS ET, Chen X, Otero PA, Moore DJ, et al
    Understanding the contributions of VPS35 and the retromer in neurodegenerative disease.
    Neurobiol Dis. 2022;170:105768.
    PubMed         Abstract available
    
    
16. RAUSCHENBERGER L, Behnke J, Grotemeyer A, Knorr S, et al
    Age-dependent neurodegeneration and neuroinflammation in a genetic A30P/A53T double-mutated alpha-synuclein mouse model of Parkinson's disease.
    Neurobiol Dis. 2022 Jun 21:105798. doi: 10.1016/j.nbd.2022.105798.
    PubMed         Abstract available
    
    
17. ERDMAN HB, Kornilov E, Kahana E, Zarchi O, et al
    Asleep DBS under ketamine sedation: Proof of concept.
    Neurobiol Dis. 2022;170:105747.
    PubMed         Abstract available
    
    

    
    Neurochem Res

18. ZAHRA W, Birla H, Singh SS, Rathore AS, et al
    Neuroprotection by Mucuna pruriens in Neurodegenerative Diseases.
    Neurochem Res. 2022;47:1816-1829.
    PubMed         Abstract available
    
    

    
    Neurol Clin Pract

19. GLENARDI G, Handayani T, Barus J, Mangkuliguna G, et al
    Inhaled Levodopa (CVT-301) for the Treatment of Parkinson Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Neurol Clin Pract. 2022;12:139-148.
    PubMed         Abstract available
    
    

    
    Neurol Genet

20. HILL EJ, Robak LA, Al-Ouran R, Deger J, et al
    Genome Sequencing in the Parkinson Disease Clinic.
    Neurol Genet. 2022;8:e200002.
    PubMed         Abstract available
    
    

    
    Neurology

21. BERGQUIST F, Ehrnebo M, Nyholm D, Johansson A, et al
    Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease.
    Neurology. 2022 Jun 15. pii: WNL.0000000000200804.
    PubMed         Abstract available
    
    

    
    Neuropsychology

22. TIMBLIN H, Rahmani E, Ryczek CA, Hill CR, et al
    Physical inactivity links depressive symptoms and cognitive functioning among individuals with Parkinson's disease.
    Neuropsychology. 2022 Jun 23. pii: 2022-74636-001. doi: 10.1037/neu0000837.
    PubMed         Abstract available
    
    

    
    Neurosci Lett

23. XU B, Wang X, Xu Z, Li Q, et al
    N-cystaminylbiguanide MC001 prevents neuron cell death and alleviates motor deficits in the MPTP-model of Parkinson's disease.
    Neurosci Lett. 2022 Jun 20:136751. doi: 10.1016/j.neulet.2022.136751.
    PubMed         Abstract available
    
    
24. LI C, Hou B, Li X, Yang Z, et al
    Role of CD36 rs1761667 AA genotype in the expression of inflammatory cytokines and Parkinson's disease progression: A case-control study in a northern Han Chinese population.
    Neurosci Lett. 2022;784:136736.
    PubMed         Abstract available
    
    
25. SHI X, Zheng J, Ma J, Wang Z, et al
    Insulin-like growth factor in Parkinson's disease is related to nonmotor symptoms and the volume of specific brain areas.
    Neurosci Lett. 2022;783:136735.
    PubMed         Abstract available
    
    
26. YANG Z, Xue L, Li C, Li M, et al
    Association between ABCA7 gene polymorphisms and Parkinson's disease susceptibility in a northern Chinese Han population.
    Neurosci Lett. 2022;784:136734.
    PubMed         Abstract available
    
    

    
    Neuroscience

27. SONG J, Liu S, Lin H
    Model-based quantitative optimization of deep brain stimulation and prediction of parkinson's states.
    Neuroscience. 2022 Jun 21. pii: S0306-4522(22)00255.
    PubMed         Abstract available
    
    

    
    PLoS One

28. CHONG-WEN W, Sha-Sha L, Xu E
    Predictors of rapid eye movement sleep behavior disorder in patients with Parkinson's disease based on random forest and decision tree.
    PLoS One. 2022;17:e0269392.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: